comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 12:11:29 - browse：55469

Medicare and money photo illustration. — Adobe

Medical technology lobby AdvaMed is fed up with the Centers for Medicare and Medicaid Services. In a letter sent to the agency and shared with STAT, the group urged CMS to act on finalizing a pathway that would make reimbursement for breakthrough devices easier.

CMS has been working on implementing the pathway since 2021. A CMS spokesperson told STAT the agency is working “expeditiously” to finalize it. Scott Whitaker, CEO of AdvaMed, said the device industry is tired of waiting.

“I myself have begun to wonder if they’re really serious about doing this, or if they’re just saying they’re serious about doing it for political reasons or otherwise,” Whitaker told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Clinical trials giant ICON acquires HumanFirst

WSS

As health system earnings go up, health insurance stocks go down

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Chemotherapy before breast cancer surgery might fuel metastasis

Pfizer highlights cancer drugs it thinks could reignite investor interest

AI for drug discovery: Experts on separating hype from reality

Brain MRIs reveal impact of 'toxic stress' on Black children

hotspot

comprehensive

focus

Affirmative action in medical school literally saved lives

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Class action alleges UnitedHealth concealed DOJ probe

Activists slam private health insurers over coverage restrictions

Class action alleges UnitedHealth concealed DOJ probe

Cancer drug shortages should be causing more outrage

The creative science of coining drug names

In Memoriam: Notable people who died in 2023

Flu vaccine offering decent levels of protection this winter, new data show

leisure time

AltruBio raises $225 million to develop ulcerative colitis drug

AstraZeneca loses challenge to Medicare drug price negotiation

RSV vaccines may be linked to small increased risk of developing GBS

Brain technologies pose threats that are all too real, experts warn

How to fix the rural physician shortage in the U.S.

RaDonda Vaught to speak at CommonSpirit event on patient safety

explore

explore

focus

leisure time